524768
EMMESSA
Invest Now
Start SIP in
EMMESSA
Performance
- Low
- ₹31
- High
- ₹37
- 52 Week Low
- ₹27
- 52 Week High
- ₹64
- Open Price₹31
- Previous Close₹33
- Volume372
Investment Returns
- Over 1 Month -1.45%
- Over 3 Month + 4.62%
- Over 6 Month -24.31%
- Over 1 Year -12.82%
Smart Investing Starts Here Start SIP with Emmessar Biotech & Nutrition for Steady Growth!
Emmessar Biotech & Nutrition Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 53.7
- PEG Ratio
- -0.9
- Market Cap Cr
- 17
- P/B Ratio
- 2.2
- Average True Range
- 2.53
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -0.26
- RSI
- 44.99
- MFI
- 44.34
Emmessar Biotech & Nutrition Financials
Emmessar Biotech & Nutrition Technicals
EMA & SMA
Current Price
₹34.00
+
1.41
(4.33%)

-
- Bearish Moving Average 7
-
- Bullish Moving Average 9
- 20 Day
- ₹33.51
- 50 Day
- ₹34.04
- 100 Day
- ₹35.43
- 200 Day
- ₹36.97
Resistance and Support
32.38
- R3 34.23
- R2 33.54
- R1 33.07
- S1 31.91
- S2 31.22
- S3 30.75
Emmessar Biotech & Nutrition Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-04-24 | Audited Results | |
2025-02-06 | Quarterly Results | |
2024-11-07 | Quarterly Results | |
2024-08-14 | Quarterly Results | |
2024-05-29 | Audited Results |
Emmessar Biotech & Nutrition F&O
About Emmessar Biotech & Nutrition
- NSE Symbol
- EMMESSA
- BSE Symbol
- 524768
- Managing Director
- Mr. Srinivasa Raghavan Mathurakavi Ayyangar
- ISIN
- INE634B01016
Similar Stocks to Emmessar Biotech & Nutrition
Emmessar Biotech & Nutrition FAQs
Emmessar Biotech & Nutrition share price is ₹34 As on 17 June, 2025 | 10:42
The Market Cap of Emmessar Biotech & Nutrition is ₹17 Cr As on 17 June, 2025 | 10:42
The P/E ratio of Emmessar Biotech & Nutrition is 53.7 As on 17 June, 2025 | 10:42
The PB ratio of Emmessar Biotech & Nutrition is 2.2 As on 17 June, 2025 | 10:42
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.